European Archives - Page 867 of 982 - European Medical Journal

Continue
5 Apr 2016

Outcomes of Salvage Lymph Node Dissection for Prostate Cancer with Clinical Nodal Relapse: Results of a Multicentric, Retrospective Study

Salvage lymph node dissection (sLND) is a treatment option for prostate cancer (PCa) patients with nodal recurrence after radical therapy to delay…
April 2016

European Medical Journal 1.2 2016

The second edition of our new eJournal series, the European Medical Journal, EMJ 1.2, is available now, and brings you a veritable range of research…
EMJ
4 Apr 2016

Mirtazapine: A New Treatment for Functional Dyspepsia

IMPROVEMENTS in many symptoms of functional dyspepsia have been observed in a pilot study of mirtazapine, an antidepressant.
EMJ
4 Apr 2016

Aspirin: A Potential Preventative Treatment for Colorectal Cancer

A NOVEL use for aspirin has recently been discovered in two long-term studies. Whilst aspirin is commonly used to treat or prevent cardiovascular disease…
EMJ
31 Mar 2016

Medics Call for Urgent Improvements in the Quality of Endoscopy across Europe

Vienna, March 30, 2016: Every year, tens of millions of individuals across Europe undergo endoscopic procedures to assist with the diagnosis and…
EMJ
29 Mar 2016

Hepatitis C Provides Potent Antiviral Molecules

RESISTANT viruses may soon face a potent new antiviral body in the form of the amphipathic α-helical (AH) peptide, a molecule found within the hepatitis…
EMJ
29 Mar 2016

Team Discover Achilles’ Heel of Liver Cancer

DEADLY liver cancer may have met its match, with the discovery of stem cell markers in the biological makeup of hepatocellular carcinoma.
EMJ
23 Mar 2016

GRANU FINK®: Effective and Well Tolerable for the Treatment of Mild to Moderate LUTS

Munich, Germany, 12-14 March, 2016: At the 31st Annual European Association of Urology (EAU) Congress the phytomedicine GRANU FINK® Prosta forte 500 mg…
EMJ
23 Mar 2016

Helsinn Presents Quality of Life, Its First Group Sustainability Report

Lugano, Switzerland, March 23, 2016: Helsinn Group is pleased to present its first group sustainability report, Quality of Life, demonstrating that…
EMJ
23 Mar 2016

Baricitinib Fights the Biological Mechanism of Rheumatoid Arthritis

A CURE-LIKE state has been achieved in a new Phase III study exploring the effects of baricitinib in rheumatoid arthritis patients with poor responses to…